Morphic Therapeutic Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 128

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $2.05B

Morphic Therapeutic General Information

Description

Operator of a biopharmaceutical company developing oral integrin therapies for the treatment of serious chronic diseases. The company specializes in applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics to the Integrins target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis and cancer.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 35 Gatehouse Drive, A2
  • Waltham, MA 02451
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 35 Gatehouse Drive, A2
  • Waltham, MA 02451
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Morphic Therapeutic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 16-Aug-2024 $2.05B Completed Generating Revenue
7. 2PO 26-Apr-2024 Completed Generating Revenue
6. PIPE 15-Feb-2023 Completed Generating Revenue
5. Secondary Transaction - Open Market 11-Feb-2020 Completed Generating Revenue
4. IPO 27-Jun-2019 Completed Generating Revenue
3. Early Stage VC (Series B) 25-Sep-2018 Completed Generating Revenue
2. Early Stage VC (Series A) 30-Jun-2016 $51.5M $58M Completed Generating Revenue
1. Seed Round 01-Jun-2015 $6.5M $6.5M Completed Generating Revenue
To view Morphic Therapeutic’s complete valuation and funding history, request access »

Morphic Therapeutic Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company developing oral integrin therapies for the treatment of serious chronic diseases
Drug Discovery
Waltham, MA
128 As of 2024

San Francisco, CA
 

West Conshohocken, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Morphic Therapeutic Competitors (66)

One of Morphic Therapeutic’s 66 competitors is Pliant Therapeutics, a Formerly VC-backed company based in San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pliant Therapeutics Formerly VC-backed San Francisco, CA
Madrigal Pharmaceuticals Formerly VC-backed West Conshohocken, PA
Sarepta Therapeutics Formerly VC-backed Cambridge, MA
Galectin Therapeutics Corporation Norcross, GA
Symphogen Formerly VC-backed Ballerup, Denmark
You’re viewing 5 of 66 competitors. Get the full list »

Morphic Therapeutic Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Morphic Therapeutic Former Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
AbbVie Ventures Corporate Venture Capital Minority
ChemPartner Corporation Minority
EcoR1 Capital Venture Capital Minority
GSK Corporation Minority
Invus (Private Equity) PE/Buyout Minority
You’re viewing 5 of 16 investors. Get the full list »

Morphic Therapeutic ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

34.48 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Biotechnology

Subindustry

of 431

Rank

Percentile

To view Morphic Therapeutic’s complete esg history, request access »

Morphic Therapeutic FAQs

  • When was Morphic Therapeutic founded?

    Morphic Therapeutic was founded in 2014.

  • Where is Morphic Therapeutic headquartered?

    Morphic Therapeutic is headquartered in Waltham, MA.

  • What is the size of Morphic Therapeutic?

    Morphic Therapeutic has 128 total employees.

  • What industry is Morphic Therapeutic in?

    Morphic Therapeutic’s primary industry is Drug Discovery.

  • Is Morphic Therapeutic a private or public company?

    Morphic Therapeutic is a Private company.

  • What is the current valuation of Morphic Therapeutic?

    The current valuation of Morphic Therapeutic is .

  • What is Morphic Therapeutic’s current revenue?

    The current revenue for Morphic Therapeutic is .

  • How much funding has Morphic Therapeutic raised over time?

    Morphic Therapeutic has raised $568M.

  • Who are Morphic Therapeutic’s investors?

    AbbVie Ventures, ChemPartner, EcoR1 Capital, GSK, and Invus (Private Equity) are 5 of 16 investors who have invested in Morphic Therapeutic.

  • Who are Morphic Therapeutic’s competitors?

    Pliant Therapeutics, Madrigal Pharmaceuticals, Sarepta Therapeutics, Galectin Therapeutics, and Symphogen are some of the 66 competitors of Morphic Therapeutic.

  • When was Morphic Therapeutic acquired?

    Morphic Therapeutic was acquired on 16-Aug-2024.

  • Who acquired Morphic Therapeutic?

    Morphic Therapeutic was acquired by Lilly USA.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process